Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Lin H. Chen, MD (she/her/hers)

Director, Travel Medicine Center Associate Professor of Medicine
Mount Auburn Hospital, Harvard Medical School
Cambridge, MA, United States

Lin H. Chen, MD, FACP, FASTMH, FISTM, is Immediate Past President of the International Society of Travel Medicine (2019-2021). She is Director of the Travel Medicine Center at Mount Auburn Hospital in Cambridge, Massachusetts, and Associate Professor of Medicine at Harvard Medical School.
Dr. Chen is a graduate of Harvard University and Jefferson Medical College of Thomas Jefferson University. She trained in Boston followed by Infectious Disease Fellowship at Yale-New Haven Hospital before returning to the Boston area. She is a Fellow of the American College of Physicians, the American Society of Tropical Medicine and Hygiene, and International Society of Travel Medicine.
She has directed the ISTM course, served on the Research Committee and the Board of Directors as a Counsellor. She served on the ASTMH Certificate Examination Committee and Education Committee and also on Work Groups of the CDC Advisory Committee on Immunization Practices.
Her editorial roles include the Journal of Travel Medicine, Current Infectious Disease Reports, Travel Medicine and Infectious Diseases, and Infectious Diseases: A Geographic Guide. She served on past scientific program committees of International Conference on Emerging Infectious Diseases and ISTM Conferences. She is a site director for the GeoSentinel Surveillance Network and Global Travel Epidemiology Network. Her clinical research focuses on travelers’ health, including vector-borne diseases, immunizations, emerging infections, and cross-border healthcare.

Disclosure(s): Merck and Company, Inc.: Honoraria (Terminated, May 2, 2023); Sanofi Pasteur Inc.: Grant/Research Support (Terminated, May 2, 2023); Shoreland Inc: Advisor/Consultant (Ongoing); Valneva: Advisor/Consultant (Ongoing)

Presentation(s):